Vaccine
Encevac® T + WNV
with Havlogen®
Indications

For vaccination of healthy horses 6 months of age or older, as an aid in the prevention of disease caused by Eastern and Western encephalomyelitis (EEE and WEE) viruses and tetanus and as an aid in reduction of disease, encephalitis and viremia caused by West Nile virus. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

The Science of Protected

  • Tetanus, WNV, EEE and WEE are core vaccinations recommended by the AAEP vaccine guidelines and are indicated in the immunization program for all horses each year.
  • Formulated to minimize reactions and maximize protection
  • West Nile virus (WNV) is the leading cause of arbovirus encephalitis in horses and humans in the United States
  • All horses are at risk of developing tetanus, an often fatal disease
  • A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), West Nile virus - flavivirus chimera and tetanus toxoid.
  • Exceptional safety profile with the smooth Havlogen® adjuvant
  • Advanced filtration process through the Antigen Purification System (APS)

Science

1 Data on file, Merck Animal Health.

Additional Resources

Administration

Dose:

For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3-4 weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.